Lurex Bio, Inc.
PrivateLast Round
Angel
Feb 5, 2026
Total Funding Raised
$125,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lurex Bio, Inc. operates in Healthcare & Life Sciences and is based in Fort Lauderdale, Florida. Its latest recorded funding round was an Angel round in February 2026.
Lurex Bio, Inc. is a biotechnology company that develops non-viral, non-genetic immune engineering platforms designed to address tumor immune evasion.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lurex Bio, Inc. Comparables
Compare Lurex Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carmine Therapeutics | 72% | |
| Isosceles Pharmaceuticals | 71% | |
| Ciloa | 68% |
For institutional investors. Book with your work email.
Lurex Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Feb 5, 2026 | ||||
| Seed Round | Jan 22, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2026
$125K raised in an Angel round.
- Jan 22, 2026
$150K seed round completed.
For institutional investors. Book with your work email.
Lurex Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lurex Bio, Inc.'s valuation, stock price, and market status.
Is Lurex Bio, Inc. a public or private company?
Lurex Bio, Inc. is a private company.
What is the current stock price of Lurex Bio, Inc.?
Lurex Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Lurex Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lurex Bio, Inc. worth (valuation)?
Valuation information for Lurex Bio, Inc. is not publicly available.
Can I buy Lurex Bio, Inc. stock?
Lurex Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lurex Bio, Inc.'s last funding round?
Lurex Bio, Inc.'s most recent funding round was Angel on February 5, 2026.
Who are the main investors in Lurex Bio, Inc.?
Investor information for Lurex Bio, Inc. is not publicly disclosed.
Will Lurex Bio, Inc. IPO soon?
No public IPO plans have been announced for Lurex Bio, Inc..
How can I track Lurex Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Lurex Bio, Inc.'s shares on secondary markets.